BARBARANN LAYTON: Open Payments
NPI 1619214491 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$165 in 9 payments from 6 companies in 2025. Trend: 2023 $86 · 2024 $219 · 2025 $165
Food & beverage: $165
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $69 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Edwards Lifesciences Corporation | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: INJECTAFER, ONPATTRO, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, Cologuard Collection Kit, Kerendia, LEQVIO.
Industry payments across PA — which companies pay providers there.
